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Abstract
Oral Squamous Cell Carcinoma has a low survival rate, 34 to 66% five-year survival after initial diagnosis, due to 
late diagnosis. Objetives: The aim of the present study was to examine the clinical features and evolution of oral 
cancer in the University of Buenos Aires. Study design: 274 patients with primary oral carcinoma, over the 1992-
2000 period were included in the study. Results: The survival rate of this population was 80% at 12 months, 60% at 
24 months, 46% at 36 months, 40% at 48 months, and 39 % at 60 months (5 years). The tumor localizations with 
worse prognosis were floor of mouth and tongue, with survival rates of 19% and 27% respectively. Sixty-five percent 
of the oral carcinomas evaluated were diagnosed at advanced stages (III and IV). Conclusions: The patients under 
study exhibited the lowest survival rate described for oral cancer (34% five-year survival after initial diagnosis). The 
population included in this study can be considered representative of the Argentine population. This bad prognosis 
would be mainly due to the large number of oral cancer cases that were diagnosed at advanced stages. 
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Introduction
Squamous Cell Carcinoma is the most frequent of oral 
carcinomas and represents approximately 3 % of all hu-
man malignant tumors.(1-3)
The main carcinogenic agents associated to the deve-
lopment of tumors of the upper aerodigestive tract are 
tobacco and alcohol.(4) Approximately between 75% and 
90% of malignant head and neck tumors have been asso-
ciated to the joint consumption of tobacco and alcohol. 
However, a recent study revealed that these risk factors act 
independently, increasing the risk of cancer compared to 
the non-smoking, non-drinking population.(5)
Grinspan et al. (6,7) were the first to describe chronic 
traumatic ulcer of dental, prosthetic or functional origin 
as a precancerous lesion. More recently, chronic trauma 
has been shown to act as a promoter in the process of oral 
carcinogenesis. (6) The oncogenic action of viruses is ac-
cepted as an important factor in the development of oral 
carcinomas. The presence of oncogenic human papilloma 
viruses, in particular types 16 and 18, cytomegalovirus and 
the Epstein Barr virus has also been associated to the deve-
lopment of oral carcinomas.(8,9) However, the literature is 
controversial regarding the transformation of the lichen. In 
a study of 719 patients with oral lichen in Buenos Aires, 32 
(6.19%) underwent malignant transformation.(10) 
Head and Neck Squamous Cell Carcinomas (HNSCC) 
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frequently present as a heterogeneous disease whose prog-
nosis is difficult to establish. The prognosis of oral cancer 
is conditioned by multiple variables such as histopatho-
logical variety, degree of tumor differentiation, extension 
and localization of the primary tumor, degree of invasion 
of neighboring structures, presence of metastatic regional 
lymph nodes, presence of distant metastases, the choice 
of therapeutic modality, and the general health status of 
the patient.(11) Oral cancers are usually diagnosed late at 
advanced stages of the disease.(12) Between 34 and 66% of 
the patients die within 5 years from diagnosis. (13-16) 
In 2005, 29.370 new cases of oral cavity and oropharyngeal 
cancer were diagnosed in USA. A total of 7.320 patients 
died(17) due to late diagnosis and disease progression. 
The aim of the present study was to analyze the clinical 
features and survival of 274 patients with primary carci-
noma of the oral cavity. 
Materials and Methods
274 patients with primary oral carcinoma who attended 
the Faculty of Dentistry, University of Buenos Aires, over 
the 1992-2000 period were included in the study. 
Our Service is considered a reference center that attends 
4000 new patients per year. Within this context, the 
population under study would be representative of the 
population of our country. 
The initial time-point of this study (t0) was the time of 
clinical and histopathological diagnosis of oral carcinoma. 
The following clinical parameters were recorded: age, sex, 
tumor localization and size, and presence of metastatic 
adenopathies.  Tumor stage was defined in keeping with 
the clinical classification TNM.(18)
The patients were followed clinically at regular intervals 
in keeping with their need of medical attention. Findings 
at follow-up were recorded and updated once every six 
months over the study period. 
Prognostic assessment of  survival was performed em-
ploying pre-established categories in keeping with the 
protocols of Kaplan Meier’s survival analysis.
Results
The mean age of the 274 patients included in the study 
was 62±13 years, with a range of 19-95 years. 
The distribution by sex, expressed as the male/female 
ratio, was 1.24/1.
The most frequent tumor sites were tongue (30%, n = 83) 
and gum (29%, n = 81). 
46% (n = 127) of the diagnosed tumors exhibited clinical 
lesions invading neighboring structures at 2 to 4 cm. 39% 
(n = 109) of the cases exhibited metastatic, unilateral and 
mobile adenopathies (Table 1). 
Of the total number of cases with an early diagnosis, 18% 
(n = 51) corresponded to stage I and 16% (n = 46) to stage 
II. 66% of the oral carcinomas evaluated was diagnosed 
at advanced stages (III and IV). 
The most frequently observed histological variant was 
Squamous Cell Carcinoma (SCC) with an incidence of 
86% (n = 237). The incidence of Verrucous Carcinoma 
(VC) was 7% (n = 19), of SCC and VC combined, 5% (n 
= 13), and of carcinoma “in situ” (Ci), 2% (n = 5).
 % n=
Age (in years)
< 40 3 9
40-49 7 19
50-59 18 49
60-69 28 78
70-79 27 73
80-89 16 43
>90 1 3
Distribution by sex
Male 55 150
Female 45 124
Tumor localization
Tongue 30 83
Gum or alveolar ridge 29 81
Cheek mucosa 18 50
Floor of mouth 10 26
Palate 9 24
Lip 4 10
Tumor size
< 2cm 29 81
2 a 4cm 46 127
> 4cm 18 48
Regional invasion 7 18
Presence of metastatic adenopathies
No adenopathies 40 111
Unilateral, mobile metastases 39 109
Bilateral, mobile metastases 11 29
Metastases fixed to deep structures 10 25
Clinical stage (TNM)
I 18 51
II 16 46
III 45 120
IV 21 57
Histological diagnosis 
Squamous Cell Carcinoma (SCC) 91 250
Verrucous Carcinoma (VC) 7 19
Carcinoma in situ 2 5
Table 1. Analysis of the clinical parameters associated to oral 
carcinoma. 
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Fig. 2. Survival curve (Kaplan Meier). A: According to the localization of oral carcinomas. B: 
According to the clinical stage of patients with oral carcinoma (TNM classification).
Fig. 1.  Survival curve of oral carcinoma (Kaplan Meier test) 
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Discussion
Updated studies of significant case series devoted to the 
analysis of the characteristics of oral cancer in Argentina 
are lacking. The present section analyzes the clinical fea-
tures of oral carcinoma in the most representative studies 
of Buenos Aires city, in the international literature and 
in our own series.  
The literature reports that 95% of oral cancers occur in 
individuals over 40 years of age and 53 % occur in indivi-
duals between 50 and 70 years of age.(19) Our case series 
shows a similar age distribution. A study by the National 
Cancer Institute of USA (1973-1984) revealed that oral 
cancer occurs in men at an earlier age (mean age 40-49 
years) than in women (over 65 years).(20,22) Our study re-
vealed statistically significant differences (p=0.01) between 
the mean age of men with oral carcinoma (59 ±13 years, 
n=174), and the mean age of women with oral carcinoma 
(63±16 years, n=154).
The increase in the incidence of oral cancer in women in 
the city of Buenos Aires is worrying.(7) The man/woman 
ratio observed by Silverman and Grinspan et al. (22) co-
rresponding to the 1950-1970 period was 7.1:1 (n=517 
patients). Schajowicz F et al.(21) reported a rate of 4.3:1 
(n=352 patients) corresponding to the 1961-1968 period; 
Brandizzi and Chuchurru et al.(7) reported a rate of 2.3:1 
(n=336 patients) corresponding to the 1972-1984 period. 
Our own series corresponding to the 1992-2000 period 
revealed a ratio of 1.24:1 (n=274 patients). 
The distribution by sex of oral cancer in societies whose 
habits are similar to ours is man/woman: 2.5-1.24/1.
(19,22)
In keeping with the literature, the tongue was the most fre-
quent localization of oral cancer in our series. A previous 
study by the National Institute of  Radiology (Buenos 
Aires, Argentina, between 1961 and 1968, n=78) reported 
a prevalence of 35%.(21) In our series prevalence was 30% 
(n=60). In considerably large USA series, these values 
varied: in a study by the Surveillance, Epidemiology and 
End Results (SEER) Program, prevalence was 30.3% in the 
1973-1979 period and 33.7% in the 1979-1984 period,(22) 
prevalence was 36.7% in North California(1) and 41.5% 
in the studies by Silverman S. et al. from University of 
California(22).  
Our study revealed a marked prevalence of gum carcino-
ma, i.e. 29% (n=58), and cheek mucosa carcinoma, i.e. 
28% (n=36).
Late diagnosis in oral cancer has been reported by several 
studies.(14) 66 to 80% of  oral malignant tumors were 
diagnosed at stages III and IV whereas only 20-34% were 
diagnosed at early stages (TNM I and II). (22-24) The 
results of the present study are in agreement with these 
findings. Morelatto RA et al. studied the role of the patient 
and acting professionals in late oral cancer diagnosis in a 
province of Argentina.(14) 
In 2005, 29.370 new cases of  oral and oropharyngeal 
Of the 274 patients included in the study, 210 had a reliable 
follow-up, with a mean of 12 months and a range of 1 to 
120 months. The survival rate of this population was 79% 
at 12 months, 60% at 24 months, 46% at 36 months, 40% 
at 48 months, and 39 % at 60 months (5 years). (Fig. 1)
Table 2 shows survival data 5 years after initial diagnosis 
according to the Kaplan Meier test for different clinical 
variables.
In the present study of oral carcinoma patients, the sur-
vival of women was significantly higher (45%) than that 
of men (31%) (Cox long rang test p<0.05).
The tumor sites with the worst prognosis were floor of 
mouth followed by tongue, with survival rates 5 years after 
initial diagnosis of 19% and 27% respectively. 
The survival of patients with Squamous Cell Carcinoma 
was 38%.
The patients with advanced stage disease exhibited a low 
survival rate (stage III 34% and stage IV 20%, 5 years after 
initial diagnosis) whereas patients with an early diagnosis 
had a good prognosis (stage I, 89% survival, 5 years after 
initial diagnosis). (Table 2)
SCC was the histological variant with the worst prognosis. 
Survival rate 5 years after initial diagnosis was 38% in the 
case of SCC and 90% in the case of VC (p<0.05, Log-rank 
Mantel-Cox Test). 
 * Survival
Age  
< = 59 years 43%
> 59 years 43%
Distribution by sex  
Male 31%  **
 Female 45%
Tumor localization  
Tongue 27%  
Gum or alveolar ridge 41%  
Cheek mucosa 54%  
Floor of mouth 19%  
Palate 54%  
Lip 100%  
Clinical stage (TNM)  
I 89%  
II 50%  
III 34%  
IV 20%  
Histological diagnosis
Squamous Cell Carcinoma (SCC) 38%
Verrucous Carcinoma (VC) 90%
Carcinoma in situ 100%
Table 2. Patient survival according to the test of Kaplan Meier for 
the different clinical variables.
*  5 years after initial diagnosis
** Log-rank Mantel-Cox Test p< 0.05.
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cancer were reported in the USA and 7.320 patients died.
(19)
Evidence of a rise in mortality rate of oral cancer has 
been reported for Cordoba, Argentina, over the 1997-
2001 period.(12) 
The literature reports that survival at 5 years after initial 
diagnosis ranges from 34-56% (13,15,16,24,25) in popu-
lations with similar socio-cultural habits to ours. Our 
series reveals a survival rate of 39% in 186 patients with 
representative clinical follow-up. This bad prognosis is 
mainly the result of a late diagnosis in a large number of 
oral tumors.(14,19) 
In our series, 65% of the cases were diagnosed at advanced 
stages (clinical stages TNM III and IV) and the survival 
rate in the case of tongue tumors was only 27%. 
The small number of patients with oral tumors at stages 
I and II (early stages of the disease) included in our study 
was due to the failure to perform an early diagnosis. 
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